Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.71 | -24.88 |
| PEG Ratio (TTM) | 0.01 | -0.42 |
| P/S Ratio (TTM) | 0.12 | 0.65 |
| P/B Ratio (TTM) | 0.59 | 1.67 |
| P/FCF Ratio (TTM) | 1.74 | -0.33 |
| Price to 5YR AVG Earnings Ratio | 1.57 | 15.30 |
| Price to 5YR AVG FCF Ratio | 9.55 | 6.51 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.82% | -0.16% |
| ROE (TTM) | -60.01% | 2.25% |
| Net Profit Margin (TTM) | -17.20% | 3.47% |
| ROIC 5YR AVG | 13.58% | 6.47% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -6.98% | 224.20% | 114.30% |
| Revenue | -3.44% | 61.80% | 39.92% |
| Net Income | -13.31% | 231.51% | 119.11% |
| Cash Flow | -93.34% | 116.35% | 106.08% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.09 | 0.63 |
| Quick Ratio (TTM) | 1.09 | 0.59 |
| D/E Ratio (TTM) | 9.50 | 3.82 |
| Interest Coverage (TTM) | -0.21 | 1.83 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | 0.23 | 0.57 |
| LTL to 5YR AVG FCF | 131.71 | 23.35 |
| Shares Outstanding Growth 5YR AVG | 2.50% | -0.12% |